Natera (NTRA) Competitors

Fresenius Medical Care (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking, profitability and dividends.

Does the MarketBeat Community favor FMS or NTRA?

Natera received 70 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.90% of users gave Natera an outperform vote while only 54.64% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Fresenius Medical Care	Outperform Votes 424 54.64%	Underperform Votes 352 45.36%
Natera	Outperform Votes 494 68.90%	Underperform Votes 223 31.10%

Which has higher earnings and valuation, FMS or NTRA?

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care	$19.49B	0.90	$540.07M	$1.12	26.68
Natera	$1.83B	11.52	-$434.80M	-$1.47	-105.12

Which has more volatility & risk, FMS or NTRA?

Fresenius Medical Care has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500.

Do analysts rate FMS or NTRA?

Fresenius Medical Care presently has a consensus price target of $27.80, indicating a potential downside of 6.96%. Natera has a consensus price target of $182.12, indicating a potential upside of 17.85%. Given Natera's stronger consensus rating and higher probable upside, analysts clearly believe Natera is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Natera	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders believe in FMS or NTRA?

8.4% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Is FMS or NTRA more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care	3.43%	6.04%	2.69%
Natera	-14.01%	-26.23%	-14.27%

Does the media favor FMS or NTRA?

In the previous week, Natera had 16 more articles in the media than Fresenius Medical Care. MarketBeat recorded 23 mentions for Natera and 7 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.60 beat Natera's score of 1.50 indicating that Fresenius Medical Care is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Natera	20 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Natera beats Fresenius Medical Care on 10 of the 18 factors compared between the two stocks.